TRANSVAGINAL DOPPLER ASSESSMENT OF OVARIAN AND ENDOMETRIAL BLOOD FLOW DURING OVULATION

Document Type : Original Article

Authors

Department of Obstetrics& Gynecology, Faculty of Medicine Al-Azhar University

Abstract

Background: Infertility is customarily defined as the inability to conceive after 1 year of regular unprotected intercourse. Assessment of the pelvis is greatly facilitated by the use of color Doppler imaging, which allows the simultaneous display of anatomic (gray scale) and flow (color) information. Quick and reproducible blood flow measurements are possible with transvaginal color Doppler.
Objective: To assess the uterine and ovarian perfusion during ovulation assessed by transvaginal color Doppler.
Patients and methods: Patients enrolled in this study were 180, which was done at October 6 University hospital during the period between September 2019 to September 2020, between 20 - 30 years old, with a previous duration of infertility ranging between 1 - 5 years and with BMI lying between 20 - 25. The patients were allocated to four groups: (group II) receiving clomiphene citrate (CC) induction alone, (group III) receiving human menopausal gonadotrophin (HMG), (group IV) receiving CC with HMG and (group I) control group receiving no medication.
Results: The deleterious effects of CC induction on endometrial thickness and pattern were clear especially in the (group II) that showed the least ratio of trilaminar endometrium among the four groups. The study showed the apparent reversing power of both spoteneous and HMG on endometrial thickness and pattern, although patients of the (Group IV) showed the highest ratio of trilaminar endometrium among the four groups. The mean day of appearance of dominant follicle was not significantly different among the 4 groups. However, it was slightly lower in the group that received CC + HMG. The three groups that received induction showed a statistically significant higher number of dominant follicles when compared with the control group, and the group that received CC+HMG showed the largest number of dominant follicles and largest diameter of the dominant follicles.
Conclusion: Use of combined transvaginal ultrasound together with color Doppler indices gave the best detection rate of ovulation than any of them alone.

Keywords

Main Subjects


TRANSVAGINAL DOPPLER ASSESSMENT OF OVARIAN AND ENDOMETRIAL BLOOD FLOW DURING OVULATION

By

Mohamed Shabaan Mahmoud, Ahmed Taha Abd El-Fattah and Abd El-Azeim Mohamed Abd El-Azeim

Department of Obstetrics& Gynecology, Faculty of Medicine Al-Azhar University

*Corresponding author: Ahmed Taha Abd El-Fattah,

E-mail: ahmedabdelfattah5045@gmail.com

ABSTRACT

Background: Infertility is customarily defined as the inability to conceive after 1 year of regular unprotected intercourse. Assessment of the pelvis is greatly facilitated by the use of color Doppler imaging, which allows the simultaneous display of anatomic (gray scale) and flow (color) information. Quick and reproducible blood flow measurements are possible with transvaginal color Doppler.

Objective: To assess the uterine and ovarian perfusion during ovulation assessed by transvaginal color Doppler.

Patients and methods: Patients enrolled in this study were 180, which was done at October 6 University hospital during the period between September 2019 to September 2020, between 20 - 30 years old, with a previous duration of infertility ranging between 1 - 5 years and with BMI lying between 20 - 25. The patients were allocated to four groups: (group II) receiving clomiphene citrate (CC) induction alone, (group III) receiving human menopausal gonadotrophin (HMG), (group IV) receiving CC with HMG and (group I) control group receiving no medication.

Results: The deleterious effects of CC induction on endometrial thickness and pattern were clear especially in the (group II) that showed the least ratio of trilaminar endometrium among the four groups. The study showed the apparent reversing power of both spoteneous and HMG on endometrial thickness and pattern, although patients of the (Group IV) showed the highest ratio of trilaminar endometrium among the four groups. The mean day of appearance of dominant follicle was not significantly different among the 4 groups. However, it was slightly lower in the group that received CC + HMG. The three groups that received induction showed a statistically significant higher number of dominant follicles when compared with the control group, and the group that received CC+HMG showed the largest number of dominant follicles and largest diameter of the dominant follicles.

Conclusion: Use of combined transvaginal ultrasound together with color Doppler indices gave the best detection rate of ovulation than any of them alone.

Keywords: Infertility, Transvaginal Doppler, Ovarian, Endometrial Blood Flow during Ovulation.

 

 

INTRODUCTION

     Infertility is defined as failure to conceive after one year of practicing sexual intercourse without any contraceptive measures. Primary infertility means that pregnancy has never occurred. While, secondary infertility means that the couple had a previous conception (irrespective of its outcome), but is unable to conceive again after one year of trying (Biswas et al., 2016).

     Clomiphene citrate (CC) is a selective estrogen receptor modu-lator (SERM) that binds to the estrogen receptors at multiple sites throughout the reproductive tract, and can act as an estrogen agonist or as an antagonist. Gonadotrophins are glycoprotein hormones that can be extracted from urine of postmenopausal women or can be manufactured by recombinant technology. They stimulate follicular growth by acting directly on ovarian follicle-stimulating hormone (FSH) receptors, and have no anti-estrogenic effect on cervical mucus or endometrium like clomiphene (Peeraer et al., 2015).

     Adequate perfusion to the endometrium is essential requirement for implantation of the embryo and therefore assessment of endometrial blood flow using color Doppler ultrasound is believed to be useful in assessing endometrial receptivity (Rai et al., 2017). A healthy endometrium is essential for reception of the fertil-ized blastocyst. An adequate endometrial blood supply is a crucial requirement for implantation (Zeng et al., 2013).

     Trans-vaginal color Doppler ultrasonography is a non-invasive and efficient method for visualizing small vessels and study of blood flow changes (Qiu et al., 2016). Doppler ultrasound has been used for several years to study the pattern of blood flow in fetal and maternal vessels. Color Doppler imaging had been used to diagnose various gynaecological disorders. Transvaginal color flow Doppler gives us an accurate tool to study the female reproductive system (Sinha et al., 2017).

     Transvaginal color Doppler imaging facilitates the detection of small vessels in the utero-ovarian circulation and measurement of impedance to flow in this vascular tree (Sinha et al., 2017). Transvaginal sonography (TVS) can be safely used as an initial investigation in the management of abnormal uterine bleeding as it is a non-invasive procedure for the detection of endometrial pathology. The incidence of detection of an abnormal pathology by TVS is high when focal lesions as fibroids or polyps are concerned (Noyes et al., 2010).

     The aim of this study was to assess the uterine and ovarian perfusion during ovulation assessed by transvaginal color Doppler.

PATIENTS AND METHODS

     This was a prospective randomized control study which done at October 6 University hospital during the period between September 2019 to September 2020, and the study  included 180 patients.

Women were divided into 4 groups:

Group (I)  (90 women) control group with normal menstrual cycles. They were selected according to clinical and ultrasonographic findings of normal uterus and ovaries with documented ovulation and menstrual cycle length of 21-35 days for at least the previous 3 cycles.

Group (II)  (30 women) were prescribed clomiphene citrate (clomid tablets, 50 mg, Aventis co, Cairo) administered orally, starting on the third day of the menstrual cycle. Treatment began with a 50 mg tablet daily for 5 consecutive days, increasing by 50 mg in subsequent cycles until ovulation is induced for at least 3 Consecutive cycles.

Group (III): (30 women) were prescribed human meoupasal gonadotrophin (EPIGONAL, epico Co, Cairo) containing (fsh +lh) 75 IU. It was taken in the form of intramuscular injection format at least 3 Consecutive cycles.

Group (IV): (30 women) were prescribed clomiphene citrate (clomid) combined with human menopausal gonadotropin (EPIGONAL ampule, Epico Co, Cairo) containing 75 IU FSH+75 IU LH. It was taken in the form of intramuscular injection, administered daily from day 3 to day 7 of menstrual cycle in a daily dose of 2 ampoules for at least 3 Consecutive cycles.

Inclusion Criteria: Age between 18-40 years old, unexplained infertility, and no hormonal contraception.

Exclusion Criteria: Infertility due to ovarian factor, infertility due to tubal disease, infertility due to uterine or cervical cause, infertility due to male factor, pregnant woman, and patient who refuse to participate in the study.

     Baseline vaginal ultrasound at the start of the cycle was to provide information on uterine and ovarian morphology and to delineate pelvic structures.

     Transvaginal ultrasound folliculometry: Monitoring was started on the 10th day of the cycle on an every other day basis after we started induction of ovulation by different drug protocols as mentioned above. The woman was placed in the supine position with flexed legs and an empty bladder. The vaginal probe was covered with coupling gel and introduced into one of the digits of a sterile surgical glove that was lubricated with coupling gel, vaginal probe (Sonoscape, SSI 6000, 7.5 MHz, China). Using the B-mode transvaginal sonography, morphology of the uterus, endometrial thickness and ovaries were explored (folliculometry). The dominant follicle was measured in three planes: after obtaining the roundest possible image using B-mode gray-scale transvaginal ultrasound, in two perpendicular dimensions at the center; cranio-caudal and transverse. All measurements were expressed in mm. The mean follicular diameter was then calculated by taking the mean of three serial measurements of the three follicular diameters. The monitoring was started on the 10th day of the cycle on an every other day basis till the dominant follicle reached 14 mm diameter when daily follow up was then performed. Human chorionic gonadotropin injection 10,000 IU IM (Pregnyl Ampoule 5000 IU, Nile Co, Cairo) was given to the patient when the dominant follicle reached 18mm in diameter. At that time, the endometrium was evaluated as regards both endometrial thickness and pattern.

     Color Doppler ultrasound was done using the transvaginal transducer with pulsed and color Doppler. The Doppler studies were better done at the same time every day as circadian rhythm is seen in uterine artery flow in periovulatory phase. The pulsatility index (PI) and resistance index (RI) of the uterine and ovarian arteries were calculated electronically when similar consecutive waveforms of good quality are obtained. Doppler flow parameters of uterine and ovarian vessels were then measured. Flow waveforms were obtained from the ascending main branch of uterine artery on the right and left side of the cervix in a longitudinal plane before it entered the uterus.

     The head of the transducer was directed into the lateral fornix of the vaginal vault and rotated 90 degrees. Therefore, a coronal section could be obtained and we were able to scan the ovaries. Lateral to and below the ovaries, a shape of a longitudinal vessel could be identified, the internal iliac artery. Thereafter, color Doppler equipment was added for monitoring ovarian blood flow on the dominant side. 10,000 IU of HCG was given to the patient IM when the dominant follicle reached 18mm in diameter.

 

     All patients were advised to have a sexual intercourse 36 & 48 hours after the HCG injection to detect pregnancy outcome.

Statistical analysis:

The collected data were coded, processed and analyzed using the SPSS (Statistical Package for the Social Sciences) version 22 for Windows® (IBM SPSS Inc, Chicago, IL, USA). For statistical analysis of categorical data, the Fisher exact test or the Chi2 test was used. Continuous data were analyzed with the unpaired (two sample) student's t test where appropriate. A probability value (P value) less than or equals 0.05 was considered significant. Accuracy was represented using the terms sensitivity, specificity, +ve predictive value and –ve predictive value.


 

RESULTS

 

 

     A total of 180 infertile patients were included in the study, 90 of them are infertile with normal semen analysis of the husband, free HSG, normal size and shape of the pelvic organs assessed by transvaginal ultrasound and 90 patients with no history of fertility problem used as control group.

     There was a statistically significant difference between group (I) and the other three groups concerning the mean age of the patients who participated in the study, but; fortunately this significant difference is in favor of the benefit of using clomid for super induction as the control group has the youngest mean age of the four groups so they have the best probability of regular and proper ovulation when compared to the older mean age of the rest of the groups i.e they have a better chance of ovulation than patients receiving treatment. At the same time, the P value for the other groups together i.e P (1#2) =1.0, P (1#3) =0,729, P (2#3) =0,746 was statistically non-significant which means that there is no special preference of patients enrolled.

     Concerning the body mass index (BMI) of the patients, the only statistically significant difference was between group (I) and group (IV); it was noted that the higher mean BMI of patients in group (IV) compared to the lower one of group (I) gave them better chance of ovulation success. At the same time, there was no significant difference between the other groups which gave them equal chances to respond to induction of ovulation. There was no statistically significant difference concerning the duration of infertility among different groups and this indicates that there is no special preference of one of groups than the others.

     Concerning the endometrial thickness, there was a statistically significant difference between group B1 and B2 (P =0.001) and, between group 1 and B 3 (P =0.006) and between group B1 and A (P =0.006). This indicates that induction of ovulation with the use of CC seriously affects the endometrial thickness and also indicates that the use of FSH or HMG can partially reverse this effect. However, the P value for group B2 and B3 (P =0.547) was statistically insignificant which indicates non superiority of either mode of treatment upon the other (Table 1).


 

Table (1):  The age, BMI, duration of infertility and endometrial thickness of the study groups

Parameters

Groups

Mean ± SD

P value

Age

Group I:

(Control)

24.42 ± 2.59

 

Group II:

(on clomid)

26.2 ± 2.5

P(1#4)=0.009

Group III:

(on HMG)

26.2 ± 2.86

P(2#4)=0.014

Group IV:

(on clomid + HMG)

25.9 ± 2.7

P(3#4)=0.027

BMI

Group I:

(Control)

22.75 ± 1.45

 

Group II:

(on clomid)

23.75 ± 1.33

P(1#4)=;0.101

P(1#2)=0.807

Group III:

(on HMG)

23.65 ± 1.79

P(2#4)=0.075;

P(2#3)=0.717

Group IV:

(on clomid + HMG)

24.85 ± 1.63

P(3#4)= 0.023;

P(3#1)=0.479

Duration of infertility

Group I:

(Control)

 

 

Group II:

(on clomid)

4.12 ± 1.14

P(1#2)=0.735

Group III:

(on HMG)

4.02 ± 1.13

P(2#3)=0.707

Group IV:

(on clomid + HMG)

3.01 ± 1.25

P(3#1)=0.957

Endometrial thickness

Group I:

(Control)

10.27 ± 1.58

 

Group II:

(on clomid)

9.17 ± 1.38

P(1#4)=0.006;

P(1#2)=0.001

Group III:

(on HMG)

10.37 ± 1.22

P(2#4)=0.785;

P(2#3)=0.547

Group IV:

(on clomid + HMG)

10.17 ± 1.33

P(3#4)=0.792;

P(3#1)=0.006

S.D = Standard deviation,

 

 

 

 

     Although the mean day of appearance of dominant follicle was slightly lower in patients receiving HMG than the rest groups; which is probably due to increased blood flow to the pelvic region and subsequently to the ovaries; yet there was no statistically significant difference that can point to the value of using HMG to achieve an earlier ovulation day in different protocols of ovulation induction.

     As regards the number of dominant follicles in patients treated by clomid, the mean was 1.83 ± 0.59 SD, while in patients treated by HMG it was 2.10 ± 0.67 SD, and this showed a highly statistically significant difference (P value= 0.001). Also, there was a statistically significant difference between groups II and III (P value= 0.005), between groups II and I (P value= 0.006), between groups III and IV (P value= 0.017) and between groups IV and I (P value= 0.002). However, the greatest number of dominant follicles was obtained in patients treated with clomid+HMG.

     As regards the diameter of dominant follicles in patients treated by clomid, the mean was 18.05±0.83 SD, while in patients treated by clomid + HMG it was 19.09 ± 0.67 SD, and this showed a highly statistically significant difference (P value= 0.001). Also, there was a statistically significant difference between groups II and III (P value= 0.005), between groups II and IV (P value= 0.006) and between groups III and IV (P value= 0.017). However, there was no statistically significant difference between groups II and I (P value= 0.444). The largest diameter of dominant follicles was obtained in patients treated with clomid +HMG (Table 2).

 

 

Table (2):  The day of appearance, mean number and diameter of dominant follicle

Parameters

Groups

Mean ± SD

P value

Day of appearance

Group II:

(clomid)

13.53 ± 1.55

P(1#4)=0.550;

P(1#2)=0.925

Group III:

(HMG)

13.57 ± 1.17

P(2#4)=0.559;

P(2#3)=0.674

Group IV:

(clomid + HMG)

13.43 ± 1.28

P(3#4)=0.350;

P(3#1)=0.786

Group I:

(Control)

13.77 ± 1.45

 

Mean number

Group II:

(clomid)

1.83 ± 0.59

P(1#4)=0.006;

P(1#2)=0.005

Group III:

(HMG)

2.10 ± 0.67

P(2#4)=0.004

P(2#3)=0.017

Group IV:

(clomid + HMG)

2.30 ± 0.65

P(3#4)=0.002;

P(3#1)=0.001

Group I:

(Control)

1.00±0.02

 

Diameter

Group II:

(clomid)

18.05±0.83

P(1#4)=0.006;

P(1#2)=0.005

Group III:

(HMG)

19.01 ± 1.56

P(2#4)=0.025

P(2#3)=0.017

Group IV:

(clomid + HMG)

19.09 ± 0.67

P(3#4)=0.444;

P(3#1)=0.001

Group I:

(Control)

18.01 ± 0.84

 

S.D = Standard deviation.

 

     Regarding the pulsatility index (PI) of the uterine artery, a statistically significant difference was obtained when we compared the pulsatility indices of different groups with each other. First, comparing the PI of groups II and I (P value=0.004) showed a significant increase in the PI of group II which indicates the deleterious effect of CC induction of ovulation on the uterine blood flow. And more importantly, comparing the other groups together showed that group IV had the lowest PI among all groups which indicates sure correction of deleterious effects of CC on uterine blood flow. In addition, although both groups III and IV showed improvement of the PI with the addition of HMG, respectively, yet the upper hand and the best improvement remains related to the use of HMG rather than Clomid. It is the effect CC induced changes in uterine pulsatility index more or less to be close to that of the control group or slightly increased. A statistically significant difference was obtained when we compared the pulsatility indices of groups II and III (P value=0.003), groups III and IV (P value=0.001), groups II and IV (P value=0.005) and groups I and IV (P value=0.003).

     There was no statistically significant difference between the different groups concerning the RI of the uterine artery although the lowest mean RI 0.65 ± 0.02 SD remained for those patients who used HMG indicating better blood flow to uterine artery.

     A statistically significant difference was obtained when we compared the pulsatility indices of the ovarian arteries of different groups with each other. First, comparing the PI of groups II and I (P value=0.001) showed a significant increase in the PI of group II indicates the deleterious effect of CC induction of ovulation on the ovarian blood flow. And more importantly, comparing the other groups together showed that group III had the lowest PI among all groups which indicates correction of deleterious effects of CC on ovarian blood flow. In addition, although both groups II and IV showed improvement of the PI with the addition of HMG, yet the upper hand and the best improvement remains related to the use of HMG than use of clomid alone.

     As regards the resistance index (RI) of the ovarian artery, there was no statistically significant difference between the different groups except concerning the statistically significant difference which was obtained when we compared the resistance index between group IV and group I (P value=0.002). The lowest mean RI of the ovarian artery 0.43 ± 0.03 SD remained for those patients who used HMG indicating better blood flow to the ovarian artery (Table 3).

 

 

 

 

 

 

 

 

 

 

 

 

 

Table (3):  The pulsatility index, resistance index of the uterine and ovarian artery.

Parameters

Groups

Mean ± SD

P value

Pulsatility index of the uterine artery

Group II:

(clomid)

2.57 ± 0.05

P(1#4)=0.004;

P(1#2)=0.003

Group III:

(HMG)

2.29 ± 0.07

P(2#4)=0.212;

P(2#3)= 0.001

Group IV:

(clomid + HMG)

2.13 ± 0.03

P(3#4)=0.003;

P(3#1)=0.005

Group I:

(Control)

2.24 ± 0.07

 

Resistance indexof the uterine artery

Group II:

(clomid)

0.64 ± 0.03

P(1#4)=0.282;

P(1#2)=0.522

Group III:

(HMG)

0.65 ± 0.01

P(2#4)=0.635;

P(2#3)= 0.242

Group IV:

(clomid + HMG)

0.63 ± 0.02

P(3#4)=0.095;

P(3#1)=0.699

Group I:

(Control)

0.65 ± 0.02

 

Pulsatility index of the ovarian artery

Group II:

(clomid)

1.06 ± 0.1

P(1#4)=0.001;

P(1#2)=0.124

Group III:

(HMG)

0.91 ± 0.1

 

P(2#4)=0.199;

P(2#3)= 0.114

Group IV:

(clomid + HMG)

0.96 ± 0.13

P(3#4)=0.130;

P(3#1)=0.054

Group I:

(Control)

1.03 ± 0.13

 

Resistance indexof the ovarian artery

Group II:

(clomid)

0.49 ± 0.8

P(1#4)=0.273;

P(1#2)=0.497

Group III:

(HMG)

0.51 ± 0.07

 

P(2#4)=0.612;

P(2#3)= 0.234

Group IV:

(clomid + HMG)

0.43 ± 0.03

P(3#4)=0.002;

P(3#1)=0.683

Group I:

(Control)

0.49 ± 0.07

 

 

Table (4):  The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of transvaginal sonography in detection of ovulation at cut off value of 18 mm follicular diameter

Cut off value of follicular diameter in mm

Sensitivity

Specificity

(+)ve PV

(-)ve PV

Accuracy

18 mm

39.4%

28.6%

72.2%

9.1%

37.5%

 

 

 

 

 

 

 

 

     As regards using the 4 Doppler indices used in detection of ovulation, they gave better results regarding the sensitivity, specificity, positive predictive value, negative predictive value and accuracy than using any one of them alone or transvaginal ultrasound alone as the figures were 62.9%, 83.3%, 98.2%, 44.5%, 65% respectively (Table 5).

 

 

Table (5):  The overall sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the 4Doppler indices alone used in detection of ovulation

Sensitivity

62.9%

Specificity

83.3%

Positive predictive value

98.2%

Negative predictive value

44.5%

Accuracy

65%

 

 

     The best results were obtained when we used combined TVS and the 4 Doppler indices in detection of ovulation as the best findings regarding the sensitivity, specificity, positive predictive value, negative predictive value and accuracy were evident than using any one of them alone or transvaginal ultrasound alone as the figures were 69.5%, 88.9%, 95.4%, 55.6%, 77% respectively (Table 6).

 

 

Table (6):  The overall sensitivity, specificity, positive predictive value, negative predictive value and accuracy of combined TVS and the 4Doppler indices used in the study in detection of ovulation

Sensitivity

69.5%

Specificity

88.9%

Positive predictive value

95.4%

Negative predictive value

55.6%

Accuracy

77%

 

 

DISCUSSION

     In the present work, we studied the role of vaginal ultrasonography and color Doppler in examination of the endometrium, uterine and ovarian vasculature in infertile patients treated with clomiphene citrate alone or with addition of human menopausal gonadotrophin (HMG) to evaluate their effects on different endometrial parameters, comparing them with other patients not receiving induction and taken as control. Color Doppler studies were performed when vaginal ultrasonography demonstrate optimum diameter of the leading follicle, i.e at the time of HCG administration.

     Although there were no preferences upon classifying the patients among the different groups, the patients chosen to receive CC+HMG induction were those with younger age groups and more or less shorter duration of infertility. This coincidence gave those patients the best chances concerning ovulation and possible pregnancy, as, according to Cai et al. (2011), the younger the patient and the shorter the duration of infertility, the better the results during ICSI. This ensures that if there are any benefits of adding HMG to CC induction, it would be the more power of the drugs to revert the changes of CC rather than a better patient profile.

     In the present study, the administration of either drug had a reversing power on the unfavorable changes in endometrial thickness due to CC induction.

     Omran et al. (2018) described that administration of clomiphene citrate resulted in reduction of endometrial thickness. In contrary, Ernest et al. (2010) found no decrease in endometrial thickness or affection of the implantation window in clomiphene citrate treated cycles.

     In this study, it was clear that the best pregnancy rate was achieved with the concomitant use of HMG rather than with the use of clomid and HMG and the mean endometrial thickness with HMG use was greater than with HMG and clomid.

     Kovacs et al. (2010) concluded that increased endometrial thickness is associated with higher pregnancy rates. However, neither attainment of pregnancy nor pregnancy outcome was predicted by endometrial thickness alone.

     Kasius et al. (2014) described that, the probability of pregnancy was significantly lower in the group with thin EMT ≤ 7 mm. This matched with Chen et al (2010) who reported that pregnancy rates ranged from 11.1% among patients with an endometrial thickness of ≤ 6 mm to 59.1% among patients with an endometrial thickness of 14-15 mm.

     The endometrium must be sufficiently thick (6-8 mm) to enable embryonic implantation (Tropea et al., 2010).

     This did not match with the result of Noyes et al. (2010) who found endometrial thickness of ≥ 14 mm in 9.6 % of IVF-ET cycles which was associated with a normal rate of pregnancy but with a higher rate of biochemical pregnancies, Noyes et al. (2010) also noted that endometrial thickness of ≥ 15 mm was found in 11.6% of IVF-ET cycles and resulted in high implantation rates and clinical pregnancies.

     In our study, definite affection of the endometrial triple layer appearance occurred in patients receiving CC alone. The percentage ratio of those with triple layered endometrium to non-triple layer was 15:85%. The use of clomid and HMG corrected this ratio to be 60:40%. Whereas; the use of HMG produced a ratio of 30:70% exactly. The net result was that the addition of HMG produced the best ratio of trilaminar endometrium which believed by many authors to be associated with better pregnancy rates than non trilaminar pattern (Kuc et al., 2011 and Zhao et al., 2012). Other studies showed no significant correlation (Bozdag et al., 2010 and Singh et al., 2011).

     As regards Doppler study of the uterine artery, in the current study, PI was statistically significant between the group that received clomid only and both groups in which (clomid and HMG) and HMG were added and also a statistically significant difference was found between the group that received clomid only and the control group. However, the difference was statistically non-significant between (clomid+ HMG) group and the control group.

     From these results, it was clear that vascular impedance is lower in the control group rather than patients receiving induction specially those receiving clomiphene citrate. This matched with Takasaki et al. (2013) who gave one possible explanation for the lower uterine perfusion seen in the induced ovarian cycles is that clomiphene citrate is shown to deplete estrogen receptors in estrogen-sensitive tissues influencing both endometrial growth and pattern show that administration of estradiol can improve uterine response in cases of poor uterine perfusion.

     In the present study, the mean PI of the uterine artery in the third group (clomid+ HMG) had the lowest value of PI of uterine artery.

     Omran et al. (2018) studied the effect of CC on uterine hemodynamics, found that uterine perfusion was better in natural cycles than stimulated ones.

     These results match with the results of Khan et al. (2016) who performed a valuable study to evaluate the prognostic value of uterine perfusion on the day of human chorionic gonadotrophin administration in patients who were undergoing intrauterine insemination. No pregnancy occurred when the pulsatility index (PI) of the ascending branch of the uterine arteries was more than 2.8. This data suggests that measurement of uterine perfusion on the day of human chorionic gonadotrophin administration may have predictive value regarding fecundity and the continuation of pregnancy.

     In the present study, the RI of the uterine artery value was statistically non-significant among different groups. The lowest mean RI was for those patients who used HMG + clomid indicating better blood flow to the uterine artery. Omran et al. (2018) found that uterine artery RI in stimulated cycles with CC was 0.84+/- 0.19 and in natural cycles was 0.78+/- 0.15.

     In this study, the mean serum progesterone level in all groups that received induction of ovulation was higher than 10 ng/ml, and the highest value was obtained with the addition of HMG to clomid.

     The study done by Warne et al. (2011) to patients who were treated with human follicle-stimulating hormone (FSH) concluded that a midluteal progesterone level <10 ng/mL may represent an appropriate threshold for inducation of ovulation resulting in live birth. Multiple pregnancies were associated with higher mean midluteal progesterone levels.

     In this study, all groups that received induction of ovulation showed a higher number of dominant follicles than the control group and the difference was statistically significant. Again, addition of HMG to clomid gave the highest mean number of dominant follicles when compared with the group that received clomid.

     This keeps with the results of the study of Chang et al. (2010) who reported that the dominant follicle number increased with total antral follicle number in women who received CC plus HMG. The pregnant group had a higher number of antral follicles and dominant follicles in comparison with the non-pregnant group. The pregnancy rate was low in women aged older than 35 years regardless of the number of antral follicles and the extent of HMG administration. Women aged older than 35 also produced fewer dominant follicles.

     Chien et al. (2012) found that women with unexplained subfertility demonstrated significant changes with time in the indices of vascularity within the endometreium during the menstrual cycle characterized by a pre-ovulatory peak and post-ovulatory fall. These changes were significantly reduced in the endometrium during the mid-late follicular phase and early luteal phase. There were no differences in endometrial thickness or volume between the groups or in the plasma concentrations of estradiol or progesterone and they concluded that endometrial and subendometrial vascularity are significantly reduced in women with unexplained subfertility during the mid-late follicular phase irrespective of estradiol or progesterone concentrations and endometrial morphometry.

     In the current study, using the 4 Doppler indices used in detection of ovulation gave better results regarding the sensitivity, specificity, positive predictive value, negative predictive value and accuracy than using any one of them alone or transvaginal ultrasound alone. These findings were consistent with those of Farrag et al. (2010) addressing the better detection and assessment of ovulation using Doppler indices.

     In this study, the best results were obtained when we used combined TVS and the 4 Doppler indices in detection of ovulation as the best findings regarding the sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 69.5%, 88.9%, 95.4%, 55.6%, 77% respectively. This is in accordance with other previous stories (Brannstorm et al., 2010, Lunenfeld et al., 2010 and Winer et al., 2011) suggesting the potential adventitious role of color Doppler imaging of ovarian blood flow in assessment of ovulation in stimulated cycles.

CONCLUSION

     The use of combined transvaginal ultrasound together with color Doppler indices gave the best detection rate of ovulation than any of them alone.

REFERENCES

  1. Biswas JK, Bandhu HC, Singh H and Dey M (2016): Relation of endometrial thickness and pregnancy rates in intrauterine insemination following ovulation induction, Int. J. Reprod. Contracept. Obstet. Gynecol., 5 (1) 110–115.
  2. Bozdag G, Esinler I and Yarali H (2010): The impact of endometrial thickness and texture on intracytoplasmatic sperm injection outcome J Reprod Med., (5) 303- 313-18.
  3. Brannstorm M, Zackrisson U, Hagstorm HG and Josefsson B (2010): Preovulatory changes of blood flow in different regions of the human follicle. Fertil Steril., 69: 435-39.
  4. Cai QF, Wan F, Huang R and Zhang HW (2011): Factors predicting the cumulative outcome of IVF/ICSI treatment: a multivariable analysis of 2450 patients. Human Reproduction, 26: 2532–2540,
  5. Chang MY, Vhiang CH, Hsieh TT, Soong YK and Hsu KH (2010): Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril., 69: 505-11.
  6. Chen SL, Wu FR, Luo C, Chen X, Shi XY, Zheng HY and Ni YP (2010): Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study Reprod Biol and Endocrinol., 8 : 30-36.
  7. Chien LW, Lee WS, Au HK and Tzeng CR (2014): Assessment of changes in utero-ovarian arterial impedance during the peri-implantation period by Doppler sonography in women undergoing assisted reproduction. Ultrasound Obstet Gynecol., 23:496–500.
  8. Ernest HYN, Carina CWC, Oi ST, William SBY and Pak PCH (2010): Comparison of endometrial and subendometrial blood flow measured by three-dimensional power Doppler ultrasound between stimulated and natural cycles in the same patients Human Reproduction, 19(10): 2385-2390.
  9. Farrag MM, Abu-Self AN, El Sirrfy A and El Atrash A (2010): Transvaginal ultrasonographic folliculometry versus Doppler ultrasound in determining ovulation. Egy. J. Obstet Gynecol., 12: 583-88.
  10. Kasius A, Smit J G, Torrance H L, Eijkemans MJ, Mol BM and Opmeer BC (2014): Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Human Reproduction Update, 20(4): 530–541.
  11. Khan MS, Shaikh A and Ratnani R (2016): Ultrasonography and Doppler Study to Predict Uterine Receptivity in Infertile Patients Undergoing Embryo Transfer. J Obstet Gynecol India, 66: 377–382.
  12. Kovacs P, Matyas S, Boda K and Kaali S (2010): The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod., 18(11):2337-4.
  13. Kuc P, Kuzcynska A, Topczewska M, Tadejko P and Kuczynski W (2011): The dynamics of endometrial growth and the triple layer appearance in three different controlled ovarian hyperstimulation protocols and their influence on IVF outcomes Gynecol Endocrinol., 11: 867- 873.
  14. Lunenfeld E, Schwartz I, Meizner I, Potashnik G and Glezerman M (2010): Intraovarian blood flow during spontaneous and stimulated cycles. Hum Reprod., 11: 24-81.
  15. Noyes N, Liu HC, Sultan K, Schattman G and Rosenwaks Z (2010): Endometrial thickness appears to be significant factor in embryo implantation in IVF. Hum Reprod., 10: 919-922.
  16. Omran E, El-Sharkawy M and El-Mazny A (2018): Effect of clomiphene citrate on uterine hemodynamics in women with unexplained infertility. Int J Womens Health, 10: 147-152.
  17. Peeraer K, Debrock S, De Loecker P, Tomassetti C, Laenen A,  Welkenhuysen M, Meeuwis L, Pelckmans S, Mol BW, Spiessens C and De Neubourg D (2015): Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial. Human Reprod., 30 (5) 1079–1088.
  18. Qiu JJ, Liu YL, Liu MH, Chen LP, Xu DW, Zhang ZX, Yang QC and Liu HB (2016): Ovarian interstitial blood flow changes assessed by transvaginal colour Doppler sonography: predicting ovarian endometrioid cyst-induced injury to ovarian interstitial vessels. Arch Gynecol Obstet., 285:427–33.
  19. Rai R, Ling YS, Yong TT, Keat AT and Rajesh H (2017): Koirala Institute of Health Int J Reprod Contracept Obstet Gynecol., 6(10):4248-4251.
  20. Singh N, Bahadur A, Mittal S, Malhotra N and Bhatt A (2011): Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hCG by 2D doppler in in-vitro fertilization cycles: A prospective clinical study from a tertiary care unit J Hum Reprod Sci., 4:29 -33.
  21. Sinha R, Prateek DS, Agarwal Y and Mahavir V (2017): Doppler flow velocities of uterine and ovarian arteries & hormonal patterns in patients with Polycystic Ovary Syndrome (PCOS). International J. of Healthcare and Biomedical Research, 5(4): 48-57.
  22. Takasaki A, Tamura H and Taketani T (2013): A pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatment. J Ovarian Res., 6: 94-102.
  23. Tropea A, Miceli F, Minici F, Orlando M, Lamanna G, Gangale M, Catino S, Lanzone A and Apa R (2010): Endometrial Evaluaiton in Superovulation Programs: Relationship with Successful Outcome. Ann NY Acad Sci., 1034(1): 211-218.
  24. Warne DW, Tredway D, Schertz JC, Schnieper-Samec S, Alam V and Eshkol A (2011): Midluteal serum progesterone levels and pregnancy following ovulation induction with human follicle-stimulating hormone: results of a combined-data analysis. J Reprod Med., 56(1-2): 31-38.
  25. Winer Z, Thaler I, Levron J, Lewit N and Itskovitz-Eldor J (2011): Assessment of ovarian and uterine blood flow by transvaginal color Doppler in ovarian-stimulated women: Correlaiton with the number of follicles and steroid hormone levels. Fertil Steril., 59: 743-749.
  26. Zeng X, Pang H and Li X (2013): Impact of obesity on endometrial blood flow in women without polycystic ovarian syndrome during intracytoplasmic sperm injection. Reprod Biol Endocrinol., 11: 57-63.
  27. Zhao J, Zhang Q and Li Y (2012): The effect of endometrial thickness and pattern measured by ultrasonography on pregnancy outcomes during IVF-ET cycles. Reprod Biol Endocrinol., 10: 100-106.


إستخدام الموجات فوق الصوتيه والدوبلر في تقييم تدفق الدم فى بطانة الرحم والمبيض وقت التبويض

محمد شعبان محمود, أحمد طه عبد الفتاح, عبد العظيم محمد عبد العظيم

قسم التوليد وأمراض النساء, کلية الطب، جامعة الأزهر

E-mail: ahmedabdelfattah5045@gmail.com

خلفية البحث: يُعرَّف العقم عادةً على أنه عدم القدرة على الحمل بعد عام واحد من الجماع المنتظم غير المحمي. يتم تسهيل تقييم الحوض إلى حد کبير من خلال استخدام تصوير دوبلر الملون، والذي يسمح بالعرض المتزامن للمعلومات التشريحية (المقياس الرمادي) والتدفق (اللوني). يمکن إجراء قياسات سريعة وقابلة للتکرار لتدفق الدم باستخدام دوبلر اللون عبر المهبل.

الهدف من البحث: تقييم نضح الرحم والمبيض أثناء التبويض بواسطة دوبلر اللون عبر المهبل.

المريضات وطرق البحث: بلغ عدد المريضات المسجلات في هذه الدراسة 180 مريضا، والتي أجريت في مستشفى جامعة 6 أکتوبر من الفترة ما بين سبتمبر 2019 إلى سبتمبر 2020، بين 20 - 30 عاما، مع فترة سابقة من العقم تتراوح ما بين 1 - 5 سنوات و مع مؤشر کتلة الجسم بين 20 - 25. وقد تم تقسيم المريضات إلى أربع مجموعات.  وقد تلقت (المجموعة (B1   تحريض سيترات الکلوميفين وحده، (المجموعة B2)   الغدد التناسلية البشرية بعد انقطاع الطمث، (المجموعة الثالثة)   سيترات الکلوميفين مع الغدد التناسلية بعد انقطاع الطمث البشري , و (المجموعة الاولى ) هى  المجموعة الضابطة لم تتلقى أي دواء.

نتائج البحث: کانت التأثيرات الضارة لتحريض سيترات الکلوميفين على سمک ونمط بطانة الرحم واضحة خاصة في المجموعة (B1) التي أظهرت أقل نسبة لبطانة الرحم ثلاثية الطبقات بين المجموعات الأربع. وأظهرت الدراسة قوة الانعکاس الواضحة لکل من الغدد التناسلية سبوتينيوس والإنسان بعد إنقطاع الطمث على سمک ونمط بطانة الرحم، على الرغم من أن المريضات من (B3) أظهرن أعلى نسبة لبطانة الرحم ثلاثية الصفائح بين المجموعات الأربع. ولم يکن متوسط يوم ظهور الجريب السائد مختلفًا بشکل کبير بين المجموعات الأربع؛ ومع ذلک، کان أقل قليلاً في المجموعة التي تلقت عقار کلوميفين سترات + موجهة الغدد التناسلية البشرية بعد إنقطاع الطمث. وقد أظهرت المجموعات الثلاث التي تلقت الاستقراء عددًا ذا دلالة إحصائية أعلى من البصيلات السائدة مقارنة بالمجموعة الضابطة، وأظهرت المجموعة التي تلقت عقار کلوميفين سترات + الغدد التناسلية بعد إنقطاع الطمث البشري أکبر عدد من البصيلات السائدة وأکبر قطر للبصيلات السائدة.

الاستنتاج: إستخدام الموجات فوق الصوتية عبر المهبل مع مؤشرات دوبلر الملونة تعطي أفضل معدل للکشف عن الإباضة من أي منهما بمفرده.

الکلمات الدالة: العقم، دوبلر عبر المهبل، المبيض، تدفق الدم في بطانة الرحم أثناء الإباضة.

  1. REFERENCES

    1. Biswas JK, Bandhu HC, Singh H and Dey M (2016): Relation of endometrial thickness and pregnancy rates in intrauterine insemination following ovulation induction, Int. J. Reprod. Contracept. Obstet. Gynecol., 5 (1) 110–115.
    2. Bozdag G, Esinler I and Yarali H (2010): The impact of endometrial thickness and texture on intracytoplasmatic sperm injection outcome J Reprod Med., (5) 303- 313-18.
    3. Brannstorm M, Zackrisson U, Hagstorm HG and Josefsson B (2010): Preovulatory changes of blood flow in different regions of the human follicle. Fertil Steril., 69: 435-39.
    4. Cai QF, Wan F, Huang R and Zhang HW (2011): Factors predicting the cumulative outcome of IVF/ICSI treatment: a multivariable analysis of 2450 patients. Human Reproduction, 26: 2532–2540,
    5. Chang MY, Vhiang CH, Hsieh TT, Soong YK and Hsu KH (2010): Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril., 69: 505-11.
    6. Chen SL, Wu FR, Luo C, Chen X, Shi XY, Zheng HY and Ni YP (2010): Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study Reprod Biol and Endocrinol., 8 : 30-36.
    7. Chien LW, Lee WS, Au HK and Tzeng CR (2014): Assessment of changes in utero-ovarian arterial impedance during the peri-implantation period by Doppler sonography in women undergoing assisted reproduction. Ultrasound Obstet Gynecol., 23:496–500.
    8. Ernest HYN, Carina CWC, Oi ST, William SBY and Pak PCH (2010): Comparison of endometrial and subendometrial blood flow measured by three-dimensional power Doppler ultrasound between stimulated and natural cycles in the same patients Human Reproduction, 19(10): 2385-2390.
    9. Farrag MM, Abu-Self AN, El Sirrfy A and El Atrash A (2010): Transvaginal ultrasonographic folliculometry versus Doppler ultrasound in determining ovulation. Egy. J. Obstet Gynecol., 12: 583-88.
    10. Kasius A, Smit J G, Torrance H L, Eijkemans MJ, Mol BM and Opmeer BC (2014): Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Human Reproduction Update, 20(4): 530–541.
    11. Khan MS, Shaikh A and Ratnani R (2016): Ultrasonography and Doppler Study to Predict Uterine Receptivity in Infertile Patients Undergoing Embryo Transfer. J Obstet Gynecol India, 66: 377–382.
    12. Kovacs P, Matyas S, Boda K and Kaali S (2010): The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod., 18(11):2337-4.
    13. Kuc P, Kuzcynska A, Topczewska M, Tadejko P and Kuczynski W (2011): The dynamics of endometrial growth and the triple layer appearance in three different controlled ovarian hyperstimulation protocols and their influence on IVF outcomes Gynecol Endocrinol., 11: 867- 873.
    14. Lunenfeld E, Schwartz I, Meizner I, Potashnik G and Glezerman M (2010): Intraovarian blood flow during spontaneous and stimulated cycles. Hum Reprod., 11: 24-81.
    15. Noyes N, Liu HC, Sultan K, Schattman G and Rosenwaks Z (2010): Endometrial thickness appears to be significant factor in embryo implantation in IVF. Hum Reprod., 10: 919-922.
    16. Omran E, El-Sharkawy M and El-Mazny A (2018): Effect of clomiphene citrate on uterine hemodynamics in women with unexplained infertility. Int J Womens Health, 10: 147-152.
    17. Peeraer K, Debrock S, De Loecker P, Tomassetti C, Laenen A,  Welkenhuysen M, Meeuwis L, Pelckmans S, Mol BW, Spiessens C and De Neubourg D (2015): Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial. Human Reprod., 30 (5) 1079–1088.
    18. Qiu JJ, Liu YL, Liu MH, Chen LP, Xu DW, Zhang ZX, Yang QC and Liu HB (2016): Ovarian interstitial blood flow changes assessed by transvaginal colour Doppler sonography: predicting ovarian endometrioid cyst-induced injury to ovarian interstitial vessels. Arch Gynecol Obstet., 285:427–33.
    19. Rai R, Ling YS, Yong TT, Keat AT and Rajesh H (2017): Koirala Institute of Health Int J Reprod Contracept Obstet Gynecol., 6(10):4248-4251.
    20. Singh N, Bahadur A, Mittal S, Malhotra N and Bhatt A (2011): Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hCG by 2D doppler in in-vitro fertilization cycles: A prospective clinical study from a tertiary care unit J Hum Reprod Sci., 4:29 -33.
    21. Sinha R, Prateek DS, Agarwal Y and Mahavir V (2017): Doppler flow velocities of uterine and ovarian arteries & hormonal patterns in patients with Polycystic Ovary Syndrome (PCOS). International J. of Healthcare and Biomedical Research, 5(4): 48-57.
    22. Takasaki A, Tamura H and Taketani T (2013): A pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatment. J Ovarian Res., 6: 94-102.
    23. Tropea A, Miceli F, Minici F, Orlando M, Lamanna G, Gangale M, Catino S, Lanzone A and Apa R (2010): Endometrial Evaluaiton in Superovulation Programs: Relationship with Successful Outcome. Ann NY Acad Sci., 1034(1): 211-218.
    24. Warne DW, Tredway D, Schertz JC, Schnieper-Samec S, Alam V and Eshkol A (2011): Midluteal serum progesterone levels and pregnancy following ovulation induction with human follicle-stimulating hormone: results of a combined-data analysis. J Reprod Med., 56(1-2): 31-38.
    25. Winer Z, Thaler I, Levron J, Lewit N and Itskovitz-Eldor J (2011): Assessment of ovarian and uterine blood flow by transvaginal color Doppler in ovarian-stimulated women: Correlaiton with the number of follicles and steroid hormone levels. Fertil Steril., 59: 743-749.
    26. Zeng X, Pang H and Li X (2013): Impact of obesity on endometrial blood flow in women without polycystic ovarian syndrome during intracytoplasmic sperm injection. Reprod Biol Endocrinol., 11: 57-63.
    27. Zhao J, Zhang Q and Li Y (2012): The effect of endometrial thickness and pattern measured by ultrasonography on pregnancy outcomes during IVF-ET cycles. Reprod Biol Endocrinol., 10: 100-106.